Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings

benzinga.com/analyst-stock-ratings/price-target/25/07/46769659/guardant-health-analysts-increase-their-forecasts-after-stronger-than-expected

Guardant Health, Inc. (NASDAQ:GH) reported better-than-expected second-quarter financial results and raised its FY25 sales guidance above estimates on Wednesday.
Guardant Health raised its FY2025 sales guidance from $880.00 million-$890.00 million to $915.00 million-$925.00 million.
“Q2…

This story appeared on benzinga.com, 2025-07-31 18:10:30.
The Entire Business World on a Single Page. Free to Use →